Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net loss	$ (106,195,167)	$ (19,919,768)
Adjustments to reconcile net loss to net cash used in operating activities:
Acquired in-process research and development	72,523,293
Depreciation and amortization	6,666	6,724
Stockbased compensation	16,885,675	3,686,060
Amortization of right of use lease asset	120,795	129,518
Foreign currency (gain) loss	(290,777)	(269,140)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	2,126,847	1,904,566
Accounts payable	2,288,527	(2,142,301)
Accrued expenses and other liabilities	(1,756,495)	(2,533,713)
Lease liability	(107,306)	(135,934)
Net cash used in operating activities	(14,397,942)	(19,273,988)
Decrease in cash and cash equivalents	(14,397,942)	(19,273,988)
Effect of exchange rate changes on cash	384,305	60,148
Cash and cash equivalents-beginning of year	53,076,052	89,017,686
Cash and cash equivalents-end of period	39,062,415	$ 69,803,846
Non-cash investing and financing activities:
Operating lease liabilities arising from obtaining right-of-use assets	123,786
Issuance of convertible preferred stock and common stock in connection with acquisition	$ 70,107,167